Podcasts about Quality of life

Welcome to Episode 108 of The Krista Escamilla Show!

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3743: Tynan shares a personal exploration of how cultivating calm transforms both productivity and quality of life. He explains why calmness allows sharper decision-making, reduces wasted energy, and creates a deeper sense of control and presence in everyday moments. Read along with the original article(s) here: http://tynan.com/calm Quotes to ponder: "Calm is a very important state to be in, and it's worth cultivating." "Calm allows you to take in more information, process it, and make better decisions." "When you are calm, you conserve energy and reduce the amount of effort necessary to live your life." Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3743: Tynan shares a personal exploration of how cultivating calm transforms both productivity and quality of life. He explains why calmness allows sharper decision-making, reduces wasted energy, and creates a deeper sense of control and presence in everyday moments. Read along with the original article(s) here: http://tynan.com/calm Quotes to ponder: "Calm is a very important state to be in, and it's worth cultivating." "Calm allows you to take in more information, process it, and make better decisions." "When you are calm, you conserve energy and reduce the amount of effort necessary to live your life." Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3743: Tynan shares a personal exploration of how cultivating calm transforms both productivity and quality of life. He explains why calmness allows sharper decision-making, reduces wasted energy, and creates a deeper sense of control and presence in everyday moments. Read along with the original article(s) here: http://tynan.com/calm Quotes to ponder: "Calm is a very important state to be in, and it's worth cultivating." "Calm allows you to take in more information, process it, and make better decisions." "When you are calm, you conserve energy and reduce the amount of effort necessary to live your life." Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Monty Pal and Dr. Mina Sedrak discuss the science behind cancer treatment-induced accelerated aging and the development of drug therapies and technologies aimed at helping older patients and cancer survivors. TRANSCRIPT Transcript: Cancer and Aging: Researching the Path to Longer, More Vibrant Lives Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I am Dr. Monty Pal. I am a medical oncologist and professor and vice chair of medical oncology here at the City of Hope Comprehensive Cancer Center. I am also host of this podcast. Today, we are going to be talking to somebody that I consider to be my little brother, if you will, in oncology, Mina Sedrak. Mina is an expert in the area of cancer and aging, which really includes the development of drug therapies and technologies that help enable older adults and survivors to live longer, healthier, and more vibrant lives. I am really excited to chat with him. He is an expert not just in cancer and aging but also breast cancer. He was my former colleague here at City of Hope before he moved over to the UCLA Jonsson Comprehensive Cancer Center, where he is an associate professor and director there of the Cancer and Aging Program. Dr. Sedrak's research involves mechanisms behind cancer treatment-induced accelerated aging and really aims to take this science into more of a therapeutic direction, which I am super, super excited about.  Mina, thanks so much for joining us today, and just FYI for our listeners, we have all of our disclosures in the transcript of this episode. Dr. Mina Sedrak: Thank you, Monty. Thank you, Dr. Pal, for having me. I am really excited to be here. Dr. Monty Pal: I feel like we have to go on a first-name basis here with how well we know each other. So Mina, you and I together have witnessed this evolution in cancer and aging. I mean, both of us worked together here with just a legendary figure in the field of geriatric oncology, I will call it, Dr. Arti Hurria, mentor to me, mentor to you, mentor to so many. Can you give us a sense of where cancer and aging has gone since the time that you and I started here together at City of Hope? Dr. Mina Sedrak: Dr. Hurria and her collaborators, Dr. [Willliam] Dale and Dr. [Supriya] Mohile, they were like huge pioneers in the field. They were one of the very first people to highlight the importance of looking at older adults beyond just their chronological age and their comorbidities and moving us beyond just seeing patients and making decisions using what we call the eyeball test. "Oh, this person looks fit or not fit, frail or robust," to really using objective measures to assess our patient's health status and incorporate that assessment into our evaluation of the treatment, prognostication, and discussions with our patients throughout the cancer continuum. And so that is what geriatric oncology has and continues to be, and it is a huge, important part. And their work has laid the foundation to show that when we look at our patients beyond just their chronological age and we look at their functional age, and we do these objective assessments, we can gain much more deeper information to tailor the treatment for our patient that is sitting in front of us, rather than do a prescriptive treatment or over- or undertreatment in that population. So that is sort of where the field is growing, and a lot of the work now is, how do we implement that? How do we put that into clinical practice? Dr. Monty Pal: Well, let me kind of spearhead that discussion, right? I have these moments when I go to the ASCO Annual Meeting – I remember this happened to me a while ago when Dr. Jennifer Temel presented that terrific work around early palliative care interventions, right? Or it even happened to me this year, right, when Dr. Christopher Booth presented the CHALLENGE trial around exercise and colon cancer. You know, these amazing, I am going to say simple, they are not simple, but they are simple interventions relative to, you know, some of the complex drugs and mechanisms that we are using nowadays that really help outcomes for our cancer patients. The big question becomes, how do you implement, right? But my understanding is that there are easy ways for us to take tools in cancer and aging and sort of plug them into our daily practice. Am I right about that? Dr. Mina Sedrak: Yes, and that is something that they are – the Cancer and Aging Research Group, which was founded by Dr. Hurria and now is co-led by Dr. Dale, Dr. Mohile, and Dr. [Heidi] Klepin, they have been incredible at really trying to develop practical tools, like the Practical Geriatric Assessment, which is now endorsed by the ASCO and other NCCN guidelines. And so, there are tools that are becoming more and more practical to help incorporate that into clinic.  Now, what might be practical in a resource-intensive setting may not be practical in some of the limited resources, whether it is rural and/or other countries where the resources may be more limited. So that is why Cristiane Bergerot, Enrique Soto, and others have been really working hard. There was actually a really beautiful paper that was just published in the Journal of Global Oncology, where they have shown that there are guidelines [ASCO Geriatric Assessment Global Guideline] about how to implement these tests, these tools, these assessments in clinical practice, even in different resource settings. So I think we are going to get to the future where this is much more – it is definitely important, but it is much more easily ‘incorporatable' into our practice. Dr. Monty Pal: Yeah, you know how close I am to Cris, and I was so proud when I saw that paper come out. That was really exciting. You know, I skimmed it. I have to tell you, I did not get into the weeds, but it was apparent to me that, you know, some of these geriatric oncology tools are things that, you know, I could probably plug and play into my practice where I am double- and triple-booked over, you know, most slots, right? I mean, I could still probably afford a little bit of time or maybe have, like, a nurse or an extender kind of help participate in the evaluation process. I thought that was, yeah, really, really interesting. Dr. Mina Sedrak: I will just say that at UCLA, we are working with Dr. Arash Naeim, who is a geriatric oncologist, and he has developed an AI platform where the assessments can be done by an AI computer. So it is like talking to your ChatGPT. They can talk to you, and for a few minutes, they will ask you the questions. So you do not even have to fill it out on a piece of paper. You could give the patient a little iPad, put them in a private room while they are waiting for their doctor, and get the results, and it is right there for you. And so, we have been trying to think about how can technology help with the completion of the assessment, at least doing that? And I think it is actually, it has been very cool. We did a pilot study. He is writing that up, and we are going to continue to do some of this exciting work. How do we think about AI in the context of this? And, you know, older adults, they are not like what they used to be. A lot of older adults are very familiar with and comfortable with phones and computers and iPads, much more so today than they were even at the time when Dr. Hurria was alive. Dr. Monty Pal: That is so interesting. You mentioned this, the AI approach is something I have been thinking about in this context because what if, for instance, you know, we have got video monitors all over our hospital, right? What if you are actually just taking a look at that patient as they make their way towards your clinic? Capture that video, use an AI algorithm to say, "Hey, you know, the timed get-up-and-go test in this patient is not particularly good based on what I am seeing here," right? There are so many ways that you could, you know, stir the pot and come up with creative ways to get these tests done. Dr. Mina Sedrak: That's right. And Arash is looking at also sensors. So he has some studies where he is putting sensors inside people's homes, where they would put them, like, on top of an Alexa app or the equivalent. A lot of people have these apps, and basically, they can sense how you are moving around and what you are doing, just movement-wise. And then they can collect that information to gain information about your life beyond just what we are seeing in the 20-minute visit in the clinic. Even when I do a walk test where I get gait speed or physical performance, short physical performance battery, the chair sit-up, those are oftentimes a single, cross-sectional, static measure. But what about the dynamic ability of capturing what has been happening for the last 7 days? What has been happening for the last 25 days between the visits, between the cycles of chemotherapy? And could that inform how I make decisions when I see patients and who do I need to target and identify? And so, we are very excited because really at UCLA, Arash is leading the technology efforts and thinking about implementation of these important measures and these important tools but leveraging new technology. And we do not want to be behind; we want to be ahead of the game. Dr. Monty Pal: I love that idea because there is a Hawthorne effect, isn't there, where you observe a process, and it naturally gets better. I mean, when you ask that patient to get up in the clinic and move, they are probably functioning to the best of their abilities, but we could probably learn a lot from just watching how fast that patient picks up a remote control at home. Some simple movement like that that is volitional would probably help out a ton. And I got to tell you, it is so funny when you mention Arash Naeim's name. I distinctly remember him serving as an attending on the wards when he was brand new at UCLA on faculty when I was a resident there. And his dad is a legendary hematopathologist, right? Dr. Mina Sedrak: I did not know that. Dr. Monty Pal: Yeah, yeah. Faramarz Naeim wrote the book on a lot of heme-path malignancies. Incredible guy. Very, very storied hematopathologist at UCLA.  I could probably go on this topic forever, but in the interest of time, I am going to shift to something that again, I could probably talk about forever, which is this area of senescence that you are involved in. You know, you had mentioned this to me, I am going to say during your outro from City of Hope and towards your transition to UCLA, it is such an exciting area. I mean, understanding the actual biologic process of aging and using those underpinnings to really sort of tailor therapy. So tell us where the state of the science is there with this body of work that you are doing. Dr. Mina Sedrak: As I said before, we have tools now to assess patients and to then do something about the deficits. So if a patient is falling, what we do is we refer them to physical therapy where they can do fall precautions and strength training to give them the information. But all of these supportive care interventions are very important. They are great. But they oftentimes are not targeting the root cause of why they are happening. And so that is really where I have been very interested in, how can we understand why is it that something like chemotherapy or immunotherapy is causing a decline in cognitive function or a decline in physical function? And so that has really led us to think about geriatric oncology rather than a discipline of older adults, but to think about aging as a physiologic process. We are all aging. As every day goes by, we are aging. And what that means is that our bodies are accumulating damage, the cells are being exposed to various stressors, and the repair mechanisms are declining. And as we get older, it is really more damage and less repair mechanism at the cellular molecular level. And it turns out that these processes of how our cells repair and respond to damage are fundamental processes of biological aging. And there has been a large amount of preclinical and now really exciting clinical work to show that there are hallmarks that could be used to assess the rate of which we age by looking at these processes. And that includes things like epigenetics, telomeres, inflammation, and something called ‘cellular senescence.' And we have been interested in my lab in senescence because it is a unique process that has an important role in aging, but it also has a really important role in cancer. Senescence is a cell state. Cells, when they are stressed, they respond to entering this state of senescence. The stress could come from anything. It could come from an oncogene activation. It could come from a reactive oxygen species. It could come from a direct damage to the cell. But it is a cell state, just like apoptosis, necrosis. Senescence is a state in which the cell, in response to that stressor, undergoes an arrest from the G to the S phase. And that arrest is oftentimes associated with a resistance to apoptosis. So then the cell does not die, but it is alive, and it remains metabolically active. And in fact, downstream pathways of these cell cycle inhibition of this G-to-S phase lead to the increase of these transcription factors in the chromatin and lead to the development of these pro-inflammatory factors. So these cells, which can occur in various tissues in the body, can continue to live despite having developed these changes, and then they secrete these proinflammatory molecules like cytokines, chemokines, metalloproteinases, all of these, which are called the senescence-associated secretory phenotype, or SASP. And as we age, we accumulate more and more of these cells, and our bodies are no longer able – our immune system, like macrophages and T cells – are no longer able to remove them effectively. And as we accumulate them in various organs, these organs release a lot of inflammatory cytokines, and the chronic inflammation in that tissue leads to the tissue being damaged, and it does not work as well, and then it starts to decline in function. And that is believed to be how senescence plays a role in aging. It is the accumulation of senescent cells that occurs with increased damage and then the repair mechanism of clearing these cells effectively, which then leads to build up of inflammation and chronic inflammation leads up to damage in multiple tissues. Dr. Monty Pal: This concept to me is fascinating. And I guess the big question is – senescence is bad, right – is it not reasonable to think that this body of research, I mean, if you are able to sort of have a meaningful impact on senescence, it could have implications well beyond oncology. Is that fair? You really could extend lifespan all around. Is that reasonable to think, all-cause mortality? Dr. Mina Sedrak: One hundred percent. And that is what they have been shown in animal models. And the reason senescence is exciting is because it turns out that you can target these cells and you can induce apoptosis of these cells, but it requires active targeting of various pathways, but it can occur. And when it does, and it is done either genetically or pharmacologically in mice, we see that the mice can reverse damage. So if you take an old mouse and you genetically engineer it to remove senescent cells, that mouse will go from being frail to fit. And if you take a young mouse and you induce senescent cells at a high rate and you accumulate them in that mouse, that mouse, even though it is young, will become frail.  So that has really led to this exciting opportunity of, can we translate this finding that we are seeing in animals and in in vivo cells, cell cultures, into humans? And could that have a benefit beyond just one disease? Could it have a benefit in multiple diseases? And not just really longevity, which I think it would be great, but what people are really looking for is, how do we live healthy as we get older? How do we move the curve so that people are not developing chronic diseases in their 60s, but they are developing them in their 80s towards shortening the period of their life with disability rather than what we have currently, which is people are living to 70s, the average life expectancy is in the mid-70s, but they are spending 10 or 11 years in disability of that life. And so, how could we reduce that time frame? Dr. Monty Pal: This is brilliant, Mina. And for our audience, this compelling dialogue that we have had here thankfully is translating to funding for Mina's work. He just scored in the second percentile for his NIH R01 based on this topic. We are so, so proud of you. I mean, it is just remarkable work. It is not easy in the current climate to get funding, and a second percentile score is just absolutely wonderful. You know, Mina, I could probably go on with you for a couple more hours here talking about your work in cancer and aging. I think I am going to have to have you back on the podcast here. But a million thanks for sharing your thoughts here today on the ASCO Daily News Podcast.  And thanks to our listeners too. If you value the insights that you heard today on the ASCO Daily News Podcast, please do not forget to rate, review, and subscribe wherever you get your podcasts. Thanks, Mina. Dr. Mina Sedrak: Thank you so much. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:     Dr. Sumanta (Monty) Pal   @montypal  Dr. Mina Sedrak @minasedrakmd   Follow ASCO on social media:      @ASCO on Twitter     ASCO on Bluesky    ASCO on Facebook      ASCO on LinkedIn      Disclosures:     Dr. Monty Pal:    Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview   Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical   Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis   Dr. Mina Sedrak: Patents, Royalties, Other Intellectual Property: Up-to-Date

Chelsea Myers, host of The Brain Crops Podcast, sat down with Jem Fuller to explore the path to the divine experience of oneness. Together, they discussed the power of pausing, reclaiming authority over your emotional experience, and how living from this place allows for the highest quality of life—without outsourcing your well-being to people, situations, or things.Jem Fuller has lived a colorful and varied life that sparked a deep curiosity about how much influence we truly have over the quality of our experiences. His journey has taken him through the study of ancient healing arts, mind practices, and over two decades of work in leadership, coaching, Neuro Linguistic Programming, human behavioral profiling, and mindfulness meditation. Jem's work centers on the resounding truth that the way we think, focus, act, and connect has profound impacts—not only on our own lives but on the lives of those around us. His mission is to share these insights in a way that empowers others to live with clarity, equanimity, and purpose.https://jemfuller.com

Summer may be winding down, but life in Orleans is just as vibrant in the fall. From crisp walks on the beach with your dog to youth sports, adult programs, cultural events, and hidden trails waiting to be discovered, Orleans is truly a year-round community.In this episode, Amanda and Mia talk with:Tom DeSiervo, Director of Recreation, Culture & Community Events – about fall programs, events, and the ways recreation helps bring our community together.Kristyna Smith, Principal Clerk for the Conservation Department – about some of Orleans' “hidden gem” properties beyond the well-known spots, and how to enjoy these places responsibly.Whether you're looking for activities to join, new places to explore, or simply a reminder of what makes Orleans special, this episode is filled with ideas for making the most of the season.Resources & LinksOrleans Recreation Department: orleansma.myrec.comOrleans Conservation Properties: https://www.town.orleans.ma.us/202/Conservation-PropertiesOrleans Community Calendar:https://website.withapps.io/orleansma

Curfews, crime and hookah bars. The city manager's plan to address quality-of-life issues.

In the 100th episode of Crime and the Courtroom, host John Collins pauses the celebration to examine the shooting death of Charlie Kirk in Utah and what it reveals about public safety, due process, and the health of civic life. Drawing on his experience in the Atlanta Olympic bombing investigation, Collins unpacks how early speculation and “wing violence” narratives can distort reality, feed polarization, and obscure root causes. He introduces the “event horizon” metaphor—the point where isolation, echo chambers, and performative media pull vulnerable people past reason—and argues that rigorous, respectful debate is a safeguard, not a threat. The episode considers the responsibilities of leaders, influencers, and platforms, and what this moment demands from parents, educators, and citizens: stronger critical-thinking skills, healthier information habits, and steadier support for law enforcement and the rule of law. If you care about clarity and courage in a noisy age, this conversation offers both context and a path forward. Issues on Trial - Tell us what you think! Season:  5 Episode:  100 Duration:  38:08 YOUTUBE CHANNELS Main Podcast Channel Highlights Channel FROM OUR SPONSOR Learn About the Innovators at Promega International Symposium on Human Identification ABOUT YOUR HOST John Morrey Collins is a leadership and expertise coach specializing in working with clients in authoritative, high-stakes occupations, but with a primary emphasis on serving leaders, professionals, and organizations that support our complicated systems of criminal and civil justice. John started his private practice, Critical Victories, in 2013 after retiring his award-winning, 20-year career as a forensic laboratory scientist and executive administrator, having served as the Director of Forensic Science for the State of Michigan. His forensic technical expertise was in the examination and testing of firearms and firearm-related evidence, having provided expert courtroom testimony in approximately 130 criminal trials, including death penalty cases and Daubert hearings. John is also the author of three books on forensic science and criminal justice reform. In 2022, he released his fourth book, “The New Superior – A Better Way to Be the One in Charge,” which is available in print and audio. John's many career highlights include his part in the forensic investigation of the Atlanta serial bombings, which included the bombing of the 1996 Olympics in Atlanta, as well as his 2013 participation in a historic meeting with the US Attorney General and other firearm experts to discuss the Sandy Hook Elementary School shooting. John has a master's degree in organizational management and is formally certified as a Senior HR Professional by the Society for Human Resource Management (SHRM). In 2012, John was trained as a professional coach by the College of Executive Coaching, and he became certified as a Gallup Strengths Coach in 2022. He lives and works near Detroit, Michigan. For more books and other information, please visit www.criticalvictories.com.

Dewayne Hart is a distinguished cybersecurity leader whose insights bridge military precision and corporate strategy. A retired U.S. Navy Chief Petty Officer, he laid the groundwork for his expert mindset in technology defence before founding Secure Managed Instructional Systems (SEMAIS) in 2014, advising clients such as PwC, Kaiser Permanente, and U.S. federal agencies. Beyond his consultancy, Dewayne has earned recognition as an author and thought leader. His 2022 book, The Cybersecurity Mindset: A Virtual and Transformational Thinking Mode, and his podcast The Chief of Cybersecurity showcase his talent for translating complex threats into actionable, human-centred guidance. Represented by The Champions Speakers Agency, Dewayne is also a leading keynote speaker who continues to inspire global audiences. Alongside his ongoing work as CEO and Founder, he delivers cutting-edge insights on leadership, AI, workforce readiness, and cyber resilience. Q1. What inspired your transition from military service to cybersecurity, and how has that background shaped your approach to the field? Dewayne Hart: "When I retired from the military about 15 years ago, I was supposed to be a leadership coach. And then during the time I was studying for my master's degree programme, I walked into the office and I noticed that a friend of mine was studying for his CISSP certification. "I picked up the book, browsed through it a couple of times and said, "You know what? I think that I want to branch into the cybersecurity industry." "And so after that I started to study the CISSP certification, passed it, and then from there I became one of the people that were interested in cybersecurity. But later on I started to do some other things such as writing, starting the podcast, and here I am today working in the cybersecurity industry. It has been very rewarding. "But I thank my friend for leaving that book on the desk because if he had not left that book there, I would probably have been a leadership coach today. Now, there's nothing wrong about being a leadership coach, but I think that the cybersecurity industry is much more rewarding." Q2. Many organisations ask, "How can we become proactive rather than reactive?" From your experience, how should businesses assess and build their security capabilities to stay ahead of threats? Dewayne Hart: "As I have walked through the industry and met a great number of people working from all walks of life, the number one question they always ask me is: how can we become proactive? "My answer is always standard and it's always the same. You need to understand your security capabilities. Your security capabilities make a determination on whether you know what's on your enterprise or whether you do not know what's on your enterprise. It can also branch into cyber visibility. Do you have visible indication of where your weaknesses are? "There are some intricate programmes that must work in tandem in order for leaders to understand their security capabilities. One is your asset management programmes. Two is your configuration management programme. "Three is your vulnerability management programme. If you can take those three programmes and have them work in tandem, you can understand your security capabilities. But also, too, adding in your cyber tools and your cyber threat intelligence programmes - those are going to help you out as well. "If you add those into your asset management, your configuration management and your vulnerability management programme, you will have an accurate indication of your security capabilities. Because if you don't have an accurate indication of your security capabilities, then this is how you create those blind spots. "Blind spots are those areas of your enterprise that are sneaking under the radar. They only become active when hackers find out where they are. So if you understand your security capabilities, then you can beat hackers to the finish line." Q3. Traditionally, the 'human el...

In Episode 20 of The Luke Coutinho Show, we dive deep into the world of Alzheimer's disease—a condition feared by many but one that can often be prevented or slowed with the right lifestyle choices.Here's what you'll explore in this episode:The science behind Alzheimer's disease and how it disrupts brain function.The role of neurons, glial cells, and the glymphatic system in brain health.How sleep, movement, and circulation influence memory and cognition.The impact of chronic inflammation, beta-amyloid plaques, and gut health on Alzheimer's progression.Key nutrition strategies: healthy fats, Omega-3s, Vitamin B12, CoQ10, and more.Practical lifestyle pillars—nutrition, sleep, exercise, emotional wellness, and circadian rhythm alignment—to prevent or slow Alzheimer's.And much more…

Music and the Quality of Life

What are Cape Town’s secrets to liveability, how do you act like a local in Barcelona and why is the UAE the best place to bring people together?See omnystudio.com/listener for privacy information.

If you had to put a number on your happiness, energy, and overall well-being—what score would you give your life right now? In this episode, Amy Hudson and Dr. James Fisher dig into the science of quality of life—how researchers actually measure it, and why it's about so much more than health stats or fitness levels. They reveal why building physical strength often leads to emotional freedom and how strength training improves mental health, social connection, and vitality. Tune in to learn how training your body can completely reshape the way you feel about your life. Amy shares her definition of quality of life. She looks beyond just physical health and considers energy, mood, and daily worries. The big question is: Am I happy—and could I be happier? Dr. Fisher explains how quality of life is measured. He breaks it down with short-form surveys like the SF-12 and SF-36 that ask people to rate their health on a simple scale from excellent to poor. The point is not the specific symptom—but your overall sense of well-being. Understand the broader meaning of quality of life. Dr. Fisher reveals it's not only about physical health or ability to work—it's also about mood, social connection, and everyday experiences.  Dr. Fisher shares: “How often during the past month have you felt so down in the dumps that nothing could cheer you up?” It's a reminder that emotional health is central to quality of life. Amy and Dr. Fisher discuss how resistance training impacts your quality of life.  A 2019 systematic review of 16 studies showed that strength training consistently improved health-related quality of life in older adults. The benefits weren't just physical metrics like cholesterol—they were about how people felt. Learn how resistance training changes perception. Participants filled out quality-of-life surveys before and after strength training interventions, and the results showed mental health, energy, and outlook improving. Dr. Fisher reveals how training affects mental and social well-being. Resistance training boosted emotional control, mental health, social function, and vitality scores.  According to Amy, people who engage in strength training don't just get stronger—they become more energized, more social, and more alive. Understand the concept of emotional role function.  Amy and Dr. Fisher unpack how it reflects control over emotions and the ability to bounce back when life feels tough. Strength training plays a role in building this resilience. Dr. Fisher shares his personal perspective. When he strength trains, it's a way to release stress, burn off anger, and reset emotionally. It's not just exercise—it's therapy for the mind. Amy explains how we experience the world depends on both our emotional and physical states. Strength training is a tool that improves both—leading to a richer, more positive quality of life. Amy and Dr. Fisher agree that resistance training can help us regulate emotions and reclaim a sense of freedom.  While we can't control everything that happens to us, we can control how we respond.     Mentioned in This Episode: The Exercise Coach - Get 2 Free Sessions! Submit your questions at StrengthChangesEverything.com     This podcast and blog are provided to you for entertainment and informational purposes only. By accessing either, you agree that neither constitute medical advice nor should they be substituted for professional medical advice or care. Use of this podcast or blog to treat any medical condition is strictly prohibited. Consult your physician for any medical condition you may be having. In no event will any podcast or blog hosts, guests, or contributors, Exercise Coach USA, LLC, Gymbot LLC, any subsidiaries or affiliates of same, or any of their respective directors, officers, employees, or agents, be responsible for any injury, loss, or damage to you or others due to any podcast or blog content.

A recap of the design-minded discussions at this year’s conference, including Bofill Taller de Arquitectura and a lighting masterclass from Santa & Cole and Marset. Plus: the importance of craft and context for any project.See omnystudio.com/listener for privacy information.

Who will lead Japan’s increasingly tumultuous political scene after Shigeru Ishiba’s resignation? Plus: Argentina’s local elections and Monocle goes to Barcelona.See omnystudio.com/listener for privacy information.

When we think of Scandinavia, three countries come immediately to mind: Norway, Sweden, and Denmark. Together, they form the heart of what we call Scandinavia, although Finland and Iceland are often included in the broader Nordic family.These countries share linguistic, cultural, and historical ties, yet each has its own distinct character, traditions, and contributions to the world.Scandinavia is often associated with breathtaking fjords, long winter nights, the Northern Lights, Viking heritage, and modern innovation. It's a blend of the old and the new, the natural and the urban.In this episode, we will uncover the essence of each Scandinavian country, explore what binds them together, and what sets them apaLet's begin with Denmark, the smallest of the Scandinavian countries, yet historically one of the most influential.Denmark sits on the Jutland Peninsula and over 400 islands, with Copenhagen as its vibrant capital city. Its geography makes it a crossroads between continental Europe and the Nordic world.Known for its maritime legacy, Denmark was once home to some of the most feared Viking raiders and traders who left a permanent mark on European history.Today, Denmark is recognized as one of the happiest countries in the world, frequently topping global rankings for quality of life, education, and social welfare.Copenhagen is not only the political and cultural hub of Denmark but also a model city for sustainability, with its bike-friendly streets and commitment to green energy.Danish culture emphasizes simplicity, comfort, and balance—a concept captured by the famous word “hygge,”which embodies coziness and well-being.The country is also known for design excellence, from furniture and architecture to its globally respected culinary scene, led by restaurants like Noma.With a small population of about six million, Denmark punches far above its weight in culture, economics, and international influence. Hosted on Acast. See acast.com/privacy for more information.

Voters in two Haverhill wards cast ballots Tuesday to narrow the field of City Council candidates in those neighborhoods.Three candidates are squaring off for two spots on the final ballot for Ward 6 city councilor in the general election in November.Incumbent Michael S. McGonagle and one of his challengers, Timothy F. Carroll Jr., appeared on WHAV's morning show and answered questions about specific issues in Ward 6. The third candidate, Oliver Aguilo, did not respond to telephone, email and social media requests for an interview.McGonagle and Carroll are Haverhill natives. Carroll is a Haverhill firefighter and former president of firefighters union local 1011. McGonagle is retired.Answers are presented in the order candidates appear on the ballot.Ward 6 faces traffic disruptions due to the Rosemont Street and Snows Brook bridge replacements? Do you plan to take steps to influence detours, ease congestion or something similar?“The reality of that is that is it is only going to get worse with those bridge changes coming up. So I think a lot of signage, I think a lot of working with the traffic and safety department,” McGonagle said.Carroll responded, “So, living up in that area, it is very difficult to detour around anything going on up there. The only thing I can say right now is that you got to be patient up there when they are doing roadwork up in that area. It's traffic from noontime to 7 p.m. on 125. You can't get up there without sitting in traffic.”For many years there has been talk of a Route 125 bypass directly into Plaistow, N.H., to avoid the bottleneck at the New Hampshire line. Do you see traffic as a concern especially as it might influence emergency vehicles?McGonagle replied, “I think from a public safety standpoint, these are all the considerations that will be talked about on a weekly basis as these projects move forward.”“The thing you can do on Route 125 is you can widen it to two lanes. That's about the only option you have. You would have to take some of the sidewalks away and some of the property going down 125 away which then you would have to fight with the homeowners going down on 125,” Carroll said.Ward 6 has an industrial section, Hilldale Avenue, near the New Hampshire border. It's been described as a wild west with mixed uses and few amenities for bicyclists. What improvements, if any, would you push along that corridor?“Should that road at some point be looked at? I believe it should. I just don't know where that money would come from right now and, with the bridge work going on now, I think the best thing we can do is monitor the speed,” McGonagle said.Carroll said, “We need more businesses in the community. That's where the money comes from. That's where we are going to keep the taxes down on our residents if we get more industrial space and more companies coming in and spending tax dollars and getting the revenues from those tax dollars.”What is Ward 6's best feature?“What I love about Ward 6 is its well-established neighborhoods,” said McGonagle.Carroll mentioned the businesses, saying, “All the restaurants on 125. I am right there. I can walk to several so I'll use that as the answer,” Carroll said.Interviews with Ward 4 candidates, Kenneth Quimby, Guy Cooper and incumbent Melissa Lewandowski are heard during the next WHAV newscast.Support the show

In the final episode of our comprehensive healthcare planning series, Kirsten and Ariana tackle one of the most misunderstood areas of healthcare planning: life-ending decisions. This episode cuts through the confusion to deliver clear, factual information about California's End of Life Option Act, the strict requirements for assisted suicide, how passive and active euthanasia differ, and why many people don't actually qualify for the options they think exist. You'll also learn how California compares to other states and what alternatives exist internationally. Whether you're planning for yourself or helping a loved one understand their options, this episode provides essential information about one of life's most difficult decisions. Knowledge is power—especially when it comes to maintaining control over your final chapter.   Time-stamped Show Notes: 0:00 Introduction 1:09 Three categories of life-ending decisions explained: assisted suicide, passive euthanasia, active euthanasia 2:12 Passive euthanasia defined - withdrawal/withholding of life-sustaining treatment (legal in California) 3:07 What is active euthanasia? Many people don't realize it's not legal in the United States 3:39 California's End of Life Option Act (2016) - medical aid in dying requirements 4:49 Strict eligibility requirements: terminal illness (6 months or less), California residency, cognitive capacity, physical ability 5:02 The three-request requirement: two oral requests 48 hours apart, plus one written, witnessed request 6:29 Physician responsibilities and the right to decline participation 7:35 California vs. Oregon comparison - residency requirements and waiting periods 9:37 Geographic distribution of assisted suicide laws across the United States 10:29 Active euthanasia discussion - the dementia dilemma and client concerns 11:40 European options for active euthanasia: Belgium, Luxembourg, the Netherlands, and Spain legal frameworks 13:27 Practical considerations for California residents seeking international options 15:12 The importance of knowledge and control in end-of-life planning

Monocle’s editors and producers join Tom Edwards and Ed Stocker live from this year’s Quality of Life Conference in Barcelona to recap their favourite moments so far.See omnystudio.com/listener for privacy information.

Monocle’s editors and producers join Tom Edwards and Ed Stocker to preview their most anticipated panellists at this year’s Quality of Life Conference in Barcelona.See omnystudio.com/listener for privacy information.

How can all of us build a life where joy and connection are just as valued as success and productivity? In this episode of The Angel Next Door Podcast, host Marcia explores how embracing the lessons of intentional aging can inform not only our personal lives but also the way we approach business and community.Dr. Kerry Burnight, acclaimed as "America's Gerontologist," joins the show to discuss her decades of experience studying aging, elder care, and the vital role of social connection in achieving a thriving, long life. Her work, including her bestselling book "Joyspan," brings practical strategies and uplifting stories that resonate across generations.This conversation is a must-listen for anyone seeking to future-proof their well-being while discovering meaning in the present. You'll discover how intentional connection can protect against isolation, why joy is a critical success metric, and actionable insights that will empower you, at any age, to live and lead with purpose. To get the latest from Dr. Kerry Burnight, you can follow her below!https://www.linkedin.com/in/dr-kerry-burnight-5b958434/https://drkerryburnight.com/Joyspan - The Art and Science of Thriving in Life's Second Half Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

WWW.ADVENTUREFREAKSSS.COM Find your Ideal Destination Here:https://adventurefreaksss.com/ideal-destination-finder/================================= How to work with me: =================================

Ep 80: In this episode of Strength To Build, I sit down with Justin Hai—entrepreneur, author, and founder of "Rebalance Health" —to dive deep into the hormone that affects us all: cortisol.We break down what cortisol really is, why it isn't always the “bad guy,” and how modern technology may actually be rewiring our stress response. Justin shares how simple lifestyle shifts (from sleep to screen time) can dramatically improve the way your body handles stress and why that's important if you're wanting fat loss or can't seem to escape the symptoms of menopause.Justin just released his new book, Stress Nation, which explores the intersection of stress, performance, and wellness. He gives us a sneak peek into some of the key lessons from the book, including practical strategies you can start applying today to improve your health.What you'll learn in this episode:The #1 reason cortisol impacts your body, energy, and long-term healthWhy too much (or too little) cortisol can affect fat loss, muscle gain, and recoveryThe hidden ways technology elevates stress and what to do about itHow supplements can support you and why some simply don't workHOW TO ENTER THE GIVEAWAY!!Follow @rebalancehealth + myself if you're not already :) (@chelseyrosehealth)Comment on my latest post & tell me what actually really helps you destress. Giveaway CLOSES Sept 9th.I will pick THREE winners to win Justin's NEW BOOK "Stress Nation" + your choice of 1 of 3 bundles Bundle 1 - Melomints + DREAM (good for everyone)Bundle 2 - Menomints + DREAM (best for menopausal women)Bundle 3 - Manmints + DREAM (for the men in your life!)Start your 7 day FREE trial of my new app HERE!Want to work one on one with Chelsey?Set up a one on one consultation call here to see if personalized online training is right for you.Join a semi-private class in LA here.Email info@chelseyrosehealth.com to inquire about one on one in person training.Follow Chelsey on Instagram:@Chelseyrosehealth@StrengthtobuildFollow Chelsey on TikTok Here."Submit a question to the show"

In today's episode, supported by Sumitomo, we spoke with Tanya B. Dorff, MD, about the use of androgen deprivation therapy (ADT) in patients with prostate cancer. Dr Dorff is section chief of the Genitourinary Disease Program, as well as a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope in Duarte, California. In our conversation, Dr Dorff discussed the role of ADT in prostate cancer management, highlighting where this class of agents fits into National Comprehensive Cancer Network guidelines and how this class has evolved with the development of LHRH antagonists and agonists. She explained how the observational OPTYX study (NCT05467176), a registry of relugolix (Orgovyx) use, aims to address safety and efficacy in combination with androgen receptor pathway inhibitors in patients with advanced prostate cancer. She also noted how early data from OPTYX presented at the 2025 ASCO Annual Meeting showed relugolix's use in localized and metastatic settings. Dorff also talked through relugolix's safety profile, particularly regarding cardiovascular risk, as well as the quality-of-life effects associated with ADT. She also addressed strategies to mitigate financial toxicity, along with the potential for future ADT-sparing treatments.

Just read the latest from NEJM? The PIpELINe Trial

In this episode of Big Butts No Lies, I sit down with Kathleen Lisson, a board-certified massage therapist specializing in lymphatic health and post-operative recovery. Together, we dive into the healing power of the lymphatic system, the role of manual lymphatic drainage, and why post-op care is about so much more than swelling and scars.Kathleen shares her personal journey into massage therapy, her experience helping plastic surgery patients feel empowered in recovery, and the surprising emotional challenges women face after surgery—from navigating relationships to redefining quality of life.We also unpack trending wellness fads, the risks of reopening incisions, and why true friends and community support are just as vital as your surgeon and aftercare team.✨ If you're preparing for or recovering from plastic surgery, this conversation is your roadmap to healing, empowerment, and feeling like you again.

Send us a textThis episode of Think Like a Dog with Andreia and Millie focuses on senior dogs and the unique care they require. The discussion highlights why training remains valuable for them at any age, the medical considerations that come with growing older, and the ways their behavior may change over time.It also covers how senior dogs adjust when new pets are introduced into the household and explores the emotional aspects of caring for them, including the difficult but necessary decisions surrounding end-of-life care.The conversation emphasizes the importance of awareness, compassion, and proactive steps to ensure senior dogs experience comfort, stability, and love in their golden years.Attend the MIK9 Masterclass:  https://www.mirrorimagek9.com/mik9masterclassSign up for Mirror Image K9 Extended: http://mirrorimagek9.com/extendedSupport the showFollow Us On Instagram: @thinklikeadogpodcast @Mirrorimagek9 @OzzieAlbiesFoundation Work with Mirror Image K9 here: https://www.mirrorimagek9.com/contactusBe Our Guest: https://www.thinklikeadogpodcast.com Learn More About The Best Chance Program: https://www.ozziealbiesfoundation.org/

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3259: David Cain reveals how everyday spending decisions can dramatically impact our long-term happiness, arguing that all purchases are investments, not just financial ones. By focusing on the real-life return of what we buy, from confidence-boosting hair paste to transformative yoga classes, we can maximize our quality of life instead of wasting money on fleeting pleasures. Read along with the original article(s) here: http://www.raptitude.com/2012/03/how-to-buy-happiness/ Quotes to ponder: "Each line item on those slips represent an investment." "The value those purchases return isn't monetary value, it's experiences." Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3259: David Cain reveals how everyday spending decisions can dramatically impact our long-term happiness, arguing that all purchases are investments, not just financial ones. By focusing on the real-life return of what we buy, from confidence-boosting hair paste to transformative yoga classes, we can maximize our quality of life instead of wasting money on fleeting pleasures. Read along with the original article(s) here: http://www.raptitude.com/2012/03/how-to-buy-happiness/ Quotes to ponder: "Each line item on those slips represent an investment." "The value those purchases return isn't monetary value, it's experiences." Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3259: David Cain reveals how everyday spending decisions can dramatically impact our long-term happiness, arguing that all purchases are investments, not just financial ones. By focusing on the real-life return of what we buy, from confidence-boosting hair paste to transformative yoga classes, we can maximize our quality of life instead of wasting money on fleeting pleasures. Read along with the original article(s) here: http://www.raptitude.com/2012/03/how-to-buy-happiness/ Quotes to ponder: "Each line item on those slips represent an investment." "The value those purchases return isn't monetary value, it's experiences." Learn more about your ad choices. Visit megaphone.fm/adchoices

Joseph Mikhael, MD, and Surbhi Sidana, MD, discuss the importance of balancing treatment intervals, managing side effects, and maximizing quality of life in multiple myeloma patients. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002713. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Acyclovir Prophylaxis Against Varicella Zoster Virus Reactivation in Multiple Myeloma Patients Treated With Bortezomib-Based Therapies: A Retrospective Analysis of 100 Patients https://pubmed.ncbi.nlm.nih.gov/22222250/ Monitoring, Prophylaxis, and Treatment of Infections in Patients With MM Receiving Bispecific Antibody Therapy: Consensus Recommendations From an Expert Panel https://pubmed.ncbi.nlm.nih.gov/37528088/ Characterization of Dysgeusia and Xerostomia in Patients With Multiple Myeloma Treated With the T-Cell Redirecting GPRC5D Bispecific Antibody Talquetamab https://pubmed.ncbi.nlm.nih.gov/38092979/ Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium https://pubmed.ncbi.nlm.nih.gov/36623248/ Incidence, Prognostic Impact and Clinical Outcomes of Renal Impairment In Patients With Multiple Myeloma: A Population-Based Registry https://pubmed.ncbi.nlm.nih.gov/31773154/ International Myeloma Working Group https://www.myeloma.org/international-myeloma-working-group IMWG Scientific and Working Committees https://www.myeloma.org/international-myeloma-working-group/imwg-scientific-working-committees

House Democratic Leader Hakeem Jeffries says he's still deciding whether to endorse Assemblymember Zohran Mamdani. Meanwhile, Staten Island will get its own NYPD Quality of Life Team starting Monday. Plus, fans can already access free practices and events at the Billie Jean King National Tennis Center as US Open Fan Week runs through Saturday.

Nancy M. Gordon, LCSW, is a grief expert, licensed therapist, consultant, #1 international best-selling author, speaker, and engaging podcast guest. Her new book, I Miss You Already: Preparing for the Unbearable Loss of Your Pet©, is a teaching memoir on anticipatory pet grief. Her private practice includes direct client coaching, speaking/podcasting, and a loss and grief training/consulting business with other animal care practitioners, especially veterinarians. Her mission is to make a difference in how loss and grief, especially pet loss, are perceived, understood, navigated, and supported through her unique methodologies. Topics covered in this episode:  Nancy's journey through anticipatory pet loss and grief Honoring the pet loss journey Understanding anticipatory grief Disenfranchised grief in veterinary medicine Navigating emotional support for clients The role of Spirituality in grief Transforming grief into growth Links & Resources:  Visit the Grow Beyond Grief website to learn more Pledge to the I Miss You Already Kickstarter project  Find Nancy Gordon on Instagram or through Linktree Find Nancy Gordon on LinkedIn  Watch the documentary, The Weight They Carry The House Call Vet Academy Resources:  Download Dr. Eve's FREE House Call & Mobile Vet Biz Plan Find out about the House Call Vet Academy online CE course Learn more about Dr. Eve Harrison Learn more about the Concierge Vet Mastermind Get your FREE Concierge Vet Starter Kit mini course Learn more about SoulShine Space For Vets. Use discount code SHINE15 for 15% OFF SoulShine Space For Vets! (Available for a limited time only! Rules and restrictions apply.) Learn more about 1-to-1 coaching for current & prospective house call & mobile vets Get House Call Vet swag Learn more about the House Call & Mobile Vet Virtual Conference Register TODAY for the House Call & Mobile Vet Virtual Conference, February 7th-8th, 2026!!!!!! Here's a special gift from me as a huge thank you for being a part of our wonderful House Call Vet Cafe podcast community! ☕️ GET 20% OFF your Four Sigmatic Mushroom Coffee when you order through this link! 4Sig truly is my favorite!!! Enjoy it in good health, my friends! Music:  In loving memory of Dr. Steve Weinberg.  Intro and outro guitar music was written, performed, and recorded by house call veterinarian Dr. Steve Weinberg.  Thank you to our sponsors!  Chronos  O3 Vets  This podcast is also available in video on our House Call Vet Cafe YouTube channel   

  Dr Tim Anderson explains how the lives of ethnic and religious minorities have changed for the worse under the new Islamist regime in Syria, Emeritus Professor Damien Kingsbury and reasons for the ongoing conflicts between Cambodia and Thailand, Dr Alison Broinowski (AWPR) talking about her work in the rain 2 Sundays ago and where the Albanese government is going with Palestine, Associate Professor Tilman Ruff AO, board member of the International Campaign to Abolish Nuclear weapons talking about his life long quest to bring an end to nuclear weapons, US peace activist Kathy Kelly with some thoughts on the situation in Palestine, and Part 2 of interview with Dr Mark Diesendorf and the way for a sustainable energy future. Head to www.3cr.org.au/hometime-tuesday for full access to links and previous podcasts

This is the 12PM All Local for Monday, August 11th, 2025.

Managing pancreatitis often involves complex decisions about drainage, best made by a multidisciplinary team. Sushant Reddy, M.D., a pancreatic surgeon, joins Andrew Gunn, M.D., an interventional radiologist, and Ali Ahmed, M.D., an interventional gastroenterologist, to explain how their unified protocol helps avoid surgical drainage in most cases. They discuss acute vs. chronic cases, pseudocyst management, and evolving strategies for pain control and follow-up care.

Dr. Hope Rugo and Dr. Kamaria Lee discuss the prevalence of financial toxicity in cancer care in the United States and globally, focusing on breast cancer, and highlight key interventions to mitigate financial hardship. TRANSCRIPT  Dr. Hope Rugo: Hello, and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I'm your host, Dr. Hope Rugo. I'm the director of the Women's Cancer Program and division chief of breast medical oncology at the City of Hope Cancer Center, and I'm also the editor-in-chief of the Educational Book. Rising healthcare costs are causing financial distress for patients and their families across the globe. Patients with cancer report financial toxicity as a major impediment to their quality of life, and its association with worse outcomes is well documented. Today, we'll be discussing how patients with breast cancer are uniquely at risk for financial toxicity. Joining me for this discussion is Dr. Kamaria Lee, a fourth-year radiation oncology resident and health equity researcher at MD Anderson Cancer Center and a co-author of the recently published article titled, "Financial Toxicity in Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?" Our full disclosures are available in the transcript of this episode.  Dr. Lee, it's great to have you on this podcast. Dr. Kamaria Lee: Hey, Dr. Rugo. Thank you so much for having me. I'm excited to be here today. I also would like to recognize my co-authors, Dr. Alexandru Eniu, Dr. Christopher Booth, Molly MacDonald, and Dr. Fumiko Chino, who worked on this book chapter with me and did a fantastic presentation on the topic at ASCO this past year. Dr. Hope Rugo: Thanks very much. We'll now just jump into the questions. We know that rising medical costs contribute to a growing financial burden on patients, which has [GC1]  [JG2]  been documented to contribute to lower quality-of-life, compromised clinical care, and worse health outcomes. How are patients with breast cancer uniquely at risk for financial toxicity? How does the problem vary within the breast cancer population in terms of age, racial and ethnic groups, and those who have metastatic disease? Dr. Kamaria Lee: Breast cancer patients are uniquely at risk of financial toxicity for several reasons. Three key reasons are that breast cancer often requires multimodal treatment. So this means patients are receiving surgery, many receive systemic therapies, including hormonal therapies, as well as radiation. And so this requires care coordination and multiple visits that can increase costs. Secondly, another key reason that patients with breast cancer are uniquely at risk for financial toxicity is that there's often a long survivorship period that includes long-term care for toxicities and continued follow-ups, and patients might also be involved in activities regarding advocacy, but also physical therapy and mental health appointments during their prolonged survivorship, which can also add costs. And a third key reason that patients with breast cancer are uniquely at risk for financial toxicity is that the patient population is primarily women. And we know that women are more likely to have increased caregiver responsibilities while also potentially working and managing their treatments, and so this is another contributor. Within the breast cancer population, those who are younger and those who are from marginalized racial/ethnic groups and those with metastatic disease have been shown to be at an increased risk. Those who are younger may be more likely to need childcare during treatment if they have kids, or they're more likely to be employed and not yet retired, which can be disrupted while receiving treatment. And those who are racial/ethnic minorities may have increased financial toxicity due to reasons that exist even after controlling for socioeconomic factors. And some of these reasons have been shown to be increased risk of job or income loss or transportation barriers during treatment. And lastly, for those with metastatic breast cancer, there can be ongoing financial distress due to the long-term care that is needed for treatment, and this can include parking, transportation, and medications while managing their metastatic disease. Dr. Hope Rugo: I think it is really important to understand these issues as you just outlined. There has been a lot of focus on financial toxicity research in recent years, and that has led to novel approaches in screening for financial hardship. Can you tell us about the new screening tools and interventions and how you can easily apply that to clinical practice, keeping in mind that people aren't at MD Anderson with a bunch of support and information on this but are in clinical practice and seeing many, many patients a day with lots of different cancers? Dr. Kamaria Lee: You're exactly right that there is incredible nuance needed in understanding how to best screen for financial hardship in different types of practices. There are multiple financial toxicity tools. The most commonly used tool is the Comprehensive Score for Financial Toxicity, also known as the COST tool. In its full form, it's an 11-item survey. There's also a summary question as well. And these questions look at objective and subjective financial burden, and it uses a five-point Likert scale. For example, one question on the full form is, "I know that I have enough money in savings, retirement, or assets to cover the cost of my treatment," and then patients are able to respond "not at all" to "very much" with a threshold score for financial toxicity risk. Of course, as you noted, one critique of having an 11-item survey is that there's limited time in patient encounters with their providers. And so recently, Thom et al validated an abbreviated two-question version of the COST tool. This validation was done in an urban comprehensive cancer center, and it was found to have a high predictive value to the full measure. We note which two questions are specifically pulled from the full measure within the book chapter. And this is one way that it can be easier for clinicians who are in a busier setting to still screen for financial toxicity with fewer questions. I also do recommend that clinicians who know their clinic's workflow the best, work with their team of nurses, financial navigators, and others to best integrate the tool into their workflow. For some, this may mean sending the two-item survey as a portal message so that patients can answer it before consults. Other times, it could mean having it on the tablet that can be done in the clinic waiting room. And so there are different ways that screening can be done, even in a busy setting, and acknowledging that different practices have different amounts of resources and time. Dr. Hope Rugo: And where would people access that easily? I recognize that that information is in your chapter, or your article that's on PubMed that will be linked to this podcast, but it is nice to just know where people could easily access that online. Dr. Kamaria Lee: Yes, and so you should be able to Google ‘the COST measure', and then there is a website that also has the forms as well. So it's also beyond the book chapter, Googling ‘the COST measure', and then online they would be able to find access to the form. Dr. Hope Rugo: And how often would you do that screening? Dr. Kamaria Lee: So, I think it's definitely important that we are as proactive as possible. And so initially, I recommend that the screening happens at the time of diagnosis, and so if it's done through the portal, it can be sent before the initial consult, or again, however, is best in the workflow. So at the time of diagnosis and then at regular intervals, so throughout the treatment process, but then also into the follow-up period as well to best understand if there's still a financial burden even after the treatments have been completed. Dr. Hope Rugo: I wonder if in the metastatic setting, you could do it at the change of treatment, you know, a month after somebody's changed treatment, because people may not be as aware of the financial constraints when they first get prescribed a drug. It's more when you hear back from how much it's going to cost. And leading into that, I think it's, what do you do with this? So, you know, this cost conversation is really important. You're going to be talking to the patient about the cost considerations when you, for example, see that there are financial issues, you're prescribing treatments. How do we implement impactful structured cost conversations with our breast cancer patients, help identify financial issues, and intervene? How do we intervene? I mean, as physicians often we aren't really all that aware, or providers, of how to address the cost. Dr. Kamaria Lee: Yes, I agree fully that another key time when to screen for financial toxicity is at that transition between treatments to best understand where they're at based off of what they've received previously for care, and then to anticipate needs when changing regimens, such as like you said in the metastatic setting. As we're collecting this information, you're right, we screen, we get this information, and what do we do? I do agree that there is a lack of knowledge among us clinicians of how do we manage this information. What is insurance? How do we manage insurance and help patients with insurance concerns? How do we help them navigate out-of-pocket costs or even the indirect costs of transportation? Those are a lot of things that are not covered in-depth in traditional medical training. And so it can be overwhelming for a lot of clinicians, not only due to time limitations in clinic, but also just having those conversations within their visit. And so what I would say, a key thing to note, is that this is another area for multidisciplinary care. So just as we're treating patients in a multidisciplinary way within oncology as we work with our medical oncology, surgical colleagues across the board, it's knowing that this is another area for multidisciplinary care. So the team members include all of the different oncologists, but it also includes team members such as financial counselors and navigators and social workers and even understanding nonprofit partners who we have who have money that can be set aside to help reduce costs for certain different aspects of treatment. Another thing I will note is that most patients with breast cancer often say they do want to have these conversations still with their clinicians. So they do still see a clinician as someone that can weigh in on the costs of their treatment or can weigh in on this other aspect of their care, even if it's not the actual medication or the radiation. And so patients do desire to hear from their clinicians about this topic, and so I think another way to make it feel less overwhelming for clinicians like ourselves is to know that even small conversations are helpful and then being knowledgeable about within your institution or, like I said, outside of it with nonprofits, being aware of who can I refer this patient to for continued follow-up and for more detailed information and resources. Dr. Hope Rugo: Are those the successful interventions? It's really referring to financial navigators? How do people identify? You know, in an academic center, we often will sort of punt this to social workers or our nurse navigators. What about in the community? What's a successful intervention example of mitigating financial toxicity? Dr. Kamaria Lee: I agree completely that the context at which people are practicing is important to note. So as you alluded to, in some bigger systems, we do have financial navigators and this has been seen to be successful in providing applications and assisting with applications for things such as pharmaceutical assistance, insurance applications, discount opportunities.  Another successful intervention are financial toxicity tumor boards, which I acknowledge might not be able to exist everywhere. But where this is possible, multidisciplinary tumor boards that include both doctors and nurses and social workers and any other members of the care team have been able to effectively decrease patients' personal spending on care costs and decrease co-pays through having a dedicated time to discuss concerns as they arise or even proactively. Otherwise, I think in the community, there are other interventions in regards to understanding different aspects of government programs that might be available for patients that are not, you know, limited to an institution, but that are more nationally available, and then again, also having the nonprofit, you know, partnerships to see other resources that patients can have access to.  And then I would also say that the indirect costs are a significant burden for many patients. So by that, I mean even parking costs, transportation, childcare. And so even though those aren't interventions necessarily with someone who is a financial navigator, I would recommend that even if it's a community practice, they discuss ways that they can help offset those indirect costs with patients with parking or if there are ways to help offset transportation costs or at least educate patients on other centers that may be closer to them or they can still receive wonderful care, and then also making sure that patients are able to even have appointments scheduled in ways that are easier for them financially.  So even if someone's receiving care out in the community where there's not a financial navigator, as clinicians or our scheduling teams, sometimes there are options to make sure if a patient wants, visits are more so on one day than throughout the week or many hours apart that can really cause loss of income due to missed work. And so there are also kind of more nuanced interventions that can happen even without a financial navigation system in place. Dr. Hope Rugo: I think that those are really good points and it is interesting when you think about financial toxicity. I mean, we worry a lot when patients can't take the drugs because they can't afford them, but there are obviously many other non-treatment, direct treatment-related issues that come up like the parking, childcare, tolls, you know, having a working car, all those kinds of things, and the unexpected things like school is out or something like that that really play a big role where they don't have alternatives. And I think that if we think about just drug costs, I think those are a big issue in the global setting. And your article did address financial toxicity in the global setting. International financial toxicity rates range from 25% of patients with breast cancer in high-income countries to nearly 80% in low- and middle-income countries or LMICs. You had cited a recent meta-analysis of the global burnout from cancer, and that article found that over half of patients faced catastrophic health expenditures. And of course, I travel internationally and have a lot of colleagues who are working in oncology in many countries, and it is really often kind of shocking from our perspective to see what people can get coverage for and how much they have to pay out-of-pocket and how much that changes, that causes a lot of disparity in access to healthcare options, even those that improve survival. Can you comment on the global impact of this problem? Dr. Kamaria Lee: I am glad that you brought this up for discussion as well. Financial toxicity is something that is a significant global issue. As you mentioned, as high as 80% of patients with breast cancer in low- and middle-income countries have had significant financial toxicity. And it's particularly notable that even when looking at breast cancer compared to other malignancies around the world, the burden appears to be worse. This has been seen even in countries with free universal healthcare. One example is Sri Lanka, where they saw high financial toxicity for their patients with breast cancer, even with this free universal healthcare. But there were also those travel costs and just additional out-of-hospital tests that were not covered. Also, literature in low- and middle-income countries shows that patients might also be borrowing money from their social networks, so from their family and their friends, to help cover their treatment costs, and in some cases, people are making daily food compromises to help offset the cost of their care. So there is a really large burden of financial toxicity generally for cancer globally, but also specifically in breast cancer, it warrants specific discussion. In the meta-analysis that you mentioned, they identified key risk factors of financial toxicity globally that included people who had a larger family size, a lower income, a lack of insurance, longer disease duration, so again, the accumulation of visits and costs and co-pay over time, and those who had multiple treatments. And so in the global setting, there is this significant burden, but then I will also note that there is a lack of literature in low-income countries on financial toxicity. So where we suspect that there is a higher burden and where we need to better understand how it's distributed and what interventions can be applied, especially culturally specific interventions for each country and community, there's less research on this topic. So there is definitely an increased need for research in financial toxicity, particularly in the global setting. Dr. Hope Rugo: Yes, and I think that goes on to how we hope that financial toxicity researchers will have approaches to large-scale multi-institutional interventions to improve financial toxicity. I think this is an enormous challenge, but one of the SWOG organizations has done some great work in this area, and a randomized trial addressing cancer-related financial hardship through the delivery of a proactive financial navigation intervention is one area that SWOG has focused on, which I think is really interesting. Of course, that's going to be US-based, which is how we might find our best paths starting. Do you think that's a good path forward, maybe that being able to provide something like that across institutions that are independent of being a cancer only academic center, or more general academic center, or a community practice? You know, is finding ways to help patients with breast cancer and their families understand and better manage financial aspects of cancer care on a national basis the next approach? Dr. Kamaria Lee: Yes, I agree that that is a good approach, and I think the proactive component is also key. We know that patients that are coming to us with any cancer, but including breast cancer, some of them have already experienced a financial burden or have recently had a job loss before even coming to us and having the added distress of our direct costs and our indirect costs. So I think being proactive when they come to us in regards to the additional burden that their cancer treatments may cause is key to try to get ahead of things as much as we can, knowing that even before they've seen us, there might be many financial concerns that they've been navigating.  I think at the national level, that allows us to try to understand things at what might be a higher level of evidence and make sure that we're able to address this for a diverse cohort of patients. I know that sometimes the enrollment can be challenging at the national level when looking at financial toxicity, as then we're involving many different types of financial navigation partners and programs, and so that can maybe make it more complex to understand the best approaches, but I think that it can be done and can really bring our understanding of important financial toxicity interventions to the next level. And then the benefit to families with the proactive component is just allowing them to feel more informed, which can help decrease anticipation, anxiety related to anticipation, and allow them to help plan things moving forward for themselves and for the whole family. Dr. Hope Rugo: Those are really good points and I wonder, I was just thinking as you were talking, that having some kind of a process where you could attach to the electronic health record, you could click on the financial toxicity survey questions that somebody filled out, and then there would be a drop-down menu for interventions or connecting you to people within your clinic or even more broadly that would be potential approaches to manage that toxicity issue so that it doesn't impact care, you know, that people aren't going to decide not to take their medication or not to come in or not to get their labs because of the cost or the transportation or the home care issues that often are a big problem, even parking, as you pointed out, at the cancer center. And actually, we had a philanthropic donor when I was at UCSF who donated a large sum of money for patient assistance, and it was interesting to then have these sequential meetings with all the stakeholders to try and decide how you would use that money. You need a big program, you need to have a way of assessing the things you can intervene with, which is really tough. In that general vein, you know, what are the governmental, institutional, and provider-level actions that are required to help clinicians do our best to do no financial harm, given the fact that we're prescribing really expensive drugs that require a lot of visits when caring for our patients with breast cancer in the curative and in the metastatic setting? Dr. Kamaria Lee: At the governmental level, there are patient assistant programs that do exist, and I think that those can continue and can become more robust. But I also think one element of those is oftentimes the programs that we have at the government level or even institutional levels might have a lot of paperwork or be harder for people with lower literacy levels to complete. And so I think the government can really try to make sure that the paperwork that is given, within reason, with all the information they need, but that the paperwork can be minimized and that there can be clear instructions, as well as increased health insurance options and, you know, medical debt forgiveness as more broad just overall interventions that are needed. I think additionally, institutions that have clinical trials can help ensure that enrollment can be at geographically diverse locations. Some trials do reimburse for travel costs, of course, but sometimes then patients need the reimbursement sooner than it comes. And so I think there's also those considerations of more so upfront funds for patients involved in clinical trials if they're going to have to travel far to be enrolled in that type of care or trying to, again, make clinical trials more available at diverse locations.  I would also say that it's important that those who design clinical trials use what is known as the “Common Sense Oncology” approach of making sure that they're designed in minimizing the use of outcomes that might have a smaller clinical benefit but may have a high financial toxicity. And that also goes to what providers can do, of understanding what's most important to a particular patient in front of them, what outcomes and what benefit, or you know, how many additional months of progression-free survival or things like that might be important to a particular patient and then also educating them and discussing what the associated financial burden is just so that they have the full picture as they make an informed decision. Dr. Hope Rugo: As much as we know. I mean, I think that that's one of the big challenges is that as we prescribe these expensive drugs and often require multiple visits, even, you know, really outside of the clinical trial setting, trying to balance the benefit versus the financial toxicity can be a huge challenge. And that's a big area, I think, that we still need help with, you know. As we have more drugs approved in the early-stage setting and treatments that could be expensive, oral medications, for example, in our Medicare population where the share of cost may be substantial upfront, you know, with an upfront cost, how do we balance the benefits versus the risk? And I think you make an important point that discussing this individually with patients after we found out what the cost is. I think warning patients about the potential for large out-of-pocket cost and asking them to contact us when they know is one way around this. You know, patients feeling like they're sort of out there with a prescription, a recommendation from their doctor, they're scared of their cancer, and they have this huge share of cost that we didn't know about. That's one challenge, and I don't know if there's any suggestions you have about how one should approach that communication with the patient. Dr. Kamaria Lee: Yes, I think part of it is truly looking at each patient as an individual and asking how much they want to know, right? So we all know that patients, some who want more information, some want less, and so I think one way to approach that is asking them about how much information do they want to know, what is most helpful to them. And then also, knowing that if you're in a well-resourced setting that does have the social workers and financial navigators, also making sure it's integrated in the multidisciplinary setting and so that they know who they can go to for what, but also know that as a clinician, you're always happy for them to bring up their concerns and that if it's something that you're not aware of, that you will connect them to the correct multidisciplinary team members who can accurately provide that additional information. Dr. Hope Rugo: Do you have any other additional comments that you'd like to mention that we haven't covered? I think the idea of a financial toxicity screen with two questions that could be implemented at change of therapy or just periodically throughout the course of treatment would be a really great thing, but I think we do need as much information on potential interventions as possible because that's really what challenges people. It's like finding out information that you can't handle. Your article provides a lot of strategies there, which I think are great and can be discussed on a practice and institutional level and applied. Dr. Kamaria Lee: Yeah, I would just like to thank you for the opportunity to discuss such an important topic within oncology and specifically for our patients with breast cancer. I agree that it can feel overwhelming, both for clinicians and patients, to navigate this topic that many of us are not as familiar with, but I would just say that the area of financial toxicity is continuing to evolve as we gather more information on most successful interventions and that our patients can often inform us on, you know, what interventions are most needed as we see them. And so you can have your thinking about it as you see individual patients of, "This person mentioned this could be more useful to them." And so I think also learning from our patients in this space that can seem overwhelming and that maybe we weren't all trained on in medical school to best understand how to approach it and how to give our patients the best care, not just medically, but also financially. Dr. Hope Rugo: Thank you, Dr. Lee, for sharing your insights with us today. Our listeners will find a link, as I mentioned earlier, to the Ed Book article we discussed today in the transcript of this episode. I think it's very useful, a useful resource, and not just for providers, but for clinic staff overall. I think this can be of great value and help open the discussion as well. Dr. Kamaria Lee: Thank you so much, Dr. Rugo. Dr. Hope Rugo: And thanks to our listeners for joining us today. Please join us again next month on By the Book for more insightful views on topics you'll be hearing at Education Sessions from ASCO meetings and our deep dives into new approaches that are shaping modern oncology. Thank you. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:       Dr. Hope Rugo  @hope.rugo  Dr. Kamaria Lee @ lee_kamaria Follow ASCO on social media:       @ASCO on X (formerly Twitter)       ASCO on Bluesky      ASCO on Facebook       ASCO on LinkedIn       Disclosures:      Dr. Hope Rugo:   Honoraria: Mylan/Viatris, Chugai Pharma  Consulting/Advisory Role: Napo Pharmaceuticals, Sanofi, Bristol Myer  Research Funding (Inst.): OBI Pharma, Pfizer, Novartis, Lilly, Merck, Daiichi Sankyo, AstraZeneca, Gilead Sciences, Hoffman La-Roche AG/Genentech, In., Stemline Therapeutics, Ambryx    Dr. Kamaria Lee: No relationships to disclose  

In this interview, Dr.SHIVA Ayyadurai, MIT PhD, Inventor of Email, Scientist, Engineer and Candidate for President, Talks about Quality of Life – The Purpose of Truth Freedom Health

Talking about disability in clinical encounters with parents, families, and patients can be very challenging. Decision-making around benefits and burdens of interventions and how they impact what future life for a child might be like inherently includes discussions of disability. However, it is easy for these conversations to view disability as something wholly negative, making it feel, or even it becoming, subject to many types of value distinctions. This can be a difficult space to navigate, especially for pediatric clinicians supporting families in informed decision making. We talk with bioethicist Jaime Konerman-Sease about the nuances of talking about disability, quality of life, and suffering, and how we can talk about disability with our patients and families.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Improving Quality of Life in Movement Disorders Through Nonmotor Symptom Management" Alex Dessy, MD, clinical assistant professor in movement disorders at Jefferson Health, shares a comprehensive look at modern-day care strategies for patients with Parkinson disease and other movement disorders. Dessy discusses the foundational role of detailed history-taking, exam-based observation, and phenomenology in diagnosing complex conditions, along with the growing utility of genetic and imaging tools. She also explains the challenges of managing nonmotor symptoms—like sleep disturbance, fatigue, and constipation—and how lifestyle strategies and interdisciplinary collaboration are often as vital as medication. Lastly, she emphasizes the importance of clear and compassionate communication with patients and families as neurology becomes increasingly therapeutic. Looking for more Movement disorders discussion? Check out the NeurologyLive® Movement disorders clinical focus page. Episode Breakdown: 1:00 – How movement disorder diagnosis is approached through history, physical exam, and phenomenology 4:05 – What makes certain movement disorder cases complex and how diagnostics like genetics and imaging are used 6:20 – Neurology News Minute 8:45 – How nonmotor symptoms in Parkinson's (fatigue, constipation, sleep) are managed with lifestyle strategies 12:30 – Approaching therapeutic communication and expectation-setting with patients and families The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Eisai Showcases Promising 4-Year Data for Alzheimer Therapy Lecanemab at AAIC 2025 IHL-42X to Enter Phase 3 Trials for Obstructive Sleep Apnea Following Positive Phase 2 Data FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

There are so many different life stages that we can prepare for before we walk through them. It's important to plan ahead as best as we can even though there are certain unknowns that go before us. In today's program, host Andrew Marcus gets to spend time with longtime friends Cliff and Erin Ursel, pastors at Westside Church in Vancouver, and unpack all stages of life: singleness, dating, engagement, marriage and raising kids. 

In first-ever study, keto diet scores vs. Parkinson's; Walk away from dementia; Loneliness can kill, but negative social ties can hasten biological aging; Researchers isolate potent memory compound from sage, rosemary; Sketchy knockoff weight loss drugs are flooding the marketplace; The popular vitamin you shouldn't take for sarcoidosis; When osteoporosis is so severe that even minor trauma causes rib fractures.

The NYPD's quality of life enforcement teams are expanding to Brooklyn after launching in the Bronx and Manhattan last month. Plus, New York City is moving forward with a plan to build new affordable and market-rate housing at the Elliott-Chelsea Houses but not before vacating its senior residents. Meanwhile, Gov. Hochul is promising to protect cannabis dispensary owners who are facing relocation after state officials already approved their licenses and locations. Also, a crackdown on cyclists and e-bike riders is impacting delivery workers. And finally, we share a few free events to get into this month.

The I Love CVille Show headlines: Is This The Golden Age Of America & The CVille Area? An Analysis On The Quality Of Life In The CVille Area CVille's Downtown Mall Voted #3 “Main Street In VA” What's Upside/Downside Of Ads On CVille Buses? Pruitt's Congress Campaign Raised $100K In 10 Days Will We See A Restaurant To Food Truck Migration Scott Smith v Fred Missel Debate, 8/8 At 1015AM Executive Offices For Rent ($350 – $975), Contact Jerry Read Viewer & Listener Comments Live On-Air The I Love CVille Show airs live Monday – Friday from 12:30 pm – 1:30 pm on The I Love CVille Network. Watch and listen to The I Love CVille Show on Facebook, Instagram, Twitter, LinkedIn, iTunes, Apple Podcast, YouTube, Spotify, Fountain, Amazon Music, Audible, Rumble and iLoveCVille.com.

Summary In this episode of Develop This!, Dennis Fraise interviews Clint O'Neill, the executive director of the Arkansas Economic Development Commission. They discuss the importance of economic development in small towns, highlighting success stories of major companies like Walmart, Tyson Foods, and Murphy USA. Clint shares insights on the role of the timber and agriculture industries in Arkansas's economy, the state's competitive advantages, and the importance of workforce development. The conversation emphasizes the need for strong relationships and community support in fostering economic growth and attracting new businesses. Takeaways Clint O'Neill leads the Arkansas Economic Development Commission. Economic development is achievable in small towns. Bentonville's growth is tied to Walmart's success. Murphy USA provides free college for local students. Arkansas is a leading rice producer in the US. Strong relationships are key to economic development success. Arkansas has a low cost of living and high quality of life. Workforce development is crucial for future economic growth. The timber industry is a significant economic driver in Arkansas. Arkansas is experiencing population growth and economic success.

A massive fire devastated a Millcreek neighborhood this weekend, displacing about 50 residents. Host Ali Vallarta and executive producer Emily Means discuss. Plus, Utah gets an "F" for quality of life, documenting Wasatch wildlife, and Bear Lake milkshakes.  Resources and references: 'It's a mass tragedy.' Several Millcreek residents to be permanently displaced after fire [FOX 13] Salt Lake City was cited for weeds on land it owns in Millcreek days before mowing there sparked apartments fire [Salt Lake Tribune] Help residents displaced by the Millcreek fire. Top States for Business These states are America's worst for quality of life in 2025 [CNBC] Join us for 801 Day at the Gallivan Center on Friday, Aug. 1. RSVP here! Become a member of City Cast Salt Lake today! It's the best way to support our work and help make sure we are around for years to come. Get all the details and sign up at membership.citycast.fm. Subscribe to Hey Salt Lake, our daily morning newsletter. You can also find us on Instagram @CityCastSLC. Looking to advertise on City Cast Salt Lake? Check out our options for podcast and newsletter ads. Learn more about the sponsors of this episode:  Tracy Aviary Workshopslc.com - use code CITYCAST for 20% off. Live Crude - Get $10 off your first CRUDE purchase with promo code CITYCASTSLC Learn more about your ad choices. Visit megaphone.fm/adchoices